Bringing the fundamentals into focus…
Back to Inovio Pharmaceuticals, Inc.
How Inovio Pharmaceuticals, Inc. stacks up
INO · against 196 other Healthcare companies of similar size
Overall
3/ 100
Near the bottom of its peers.
Ranked #196 of 197 · scores higher than 1% of peers
Bars: peers in each 10-point band of the overall score6 peers with an overall score of 0–9, including INO · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around INO| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 2 | 592M ILS (≈$160M) | 84 | 99 | 99 | 96 | 1 / 2 | |
| 3 | 356M AUD (≈$235M) | 81 | 98 | 35 | 97 | 0 / 2 | |
| 4 | 256M USD | 80 | 98 | 35 | 92 | 0 / 2 | |
| 5 | 1.3B BRL (≈$238M) | 77 | 96 | 72 | 89 | 1 / 2 | |
| 192 | 2.1B CNY (≈$291M) | 9 | 0 | 3 | 24 | 2 / 2 | |
| 193 | 115M USD | 8 | 8 | — | 15 | 2 / 2 | |
| 193 | 94M USD | 8 | 8 | — | 1 | 2 / 2 | |
| 195 | 454M AUD (≈$299M) | 7 | 0 | 3 | 2 / 2 | ||
| 196 | 172M USD | 3 | 8 | 0 | 0 | 2 / 2 | |
| 197 | 153M AUD (≈$101M) | 0 | 0 | — | 0 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score